INTRODUCTION
Infection with HIV-1 is usually characterized by a gradual and inexorable depletion of CD4 ؉ T lymphocytes. The importance of the loss of these cells in the development of AIDS is unquestioned, as it correlates with the loss of immune capabilities and the consequent occurrence and severity of opportunistic infections and HIV-1-associated neoplasms. However, understanding the mechanisms by which HIV-1 causes CD4 ؉ T cell loss remains one of the unanswered questions in the AIDS field. Many mechanisms have been proposed to explain how HIV-1 causes depletion of CD4 ؉ T cells and the earliest theorized that virus replication in CD4 ؉ T cells resulted in their death or that virus-specific CTLs killed these infected cells. However, elimination of productively infected cells could not explain the significant loss of CD4 ؉ T cells [1] , as few cells in vivo are producing virus at any given time (approximately one in 10 5 cells) [2, 3] . Recent studies suggest that depletion of CD4
؉ T cells mainly occurs in lymphoid tissues of the gastrointestinal tract [4, 5] , but the loss of these cells in the gut is not mirrored in the blood and lymph nodes. In fact, CD4
؉ T cell depletion occurs in the "effecter area" of gut (lamina propria) not in the "inductive area" (Peyer's patches), where most of the cells producing virus reside. It has also been shown that increased numbers of CD4
؉ cells are dying in peripheral lymphoid tissues of HIV-infected subjects, but cells replicating HIV-1 are not the principal cells dying; uninfected, neighboring cells are dying [6] . Therefore, most theories about how HIV-1 depletes CD4
؉ T cells now depict ways uninfected bystander cells can be eliminated. Some early studies indicated that HIVgp120 binding to CD4 and CXCR4 receptors induced apoptosis [7, 8] . All of these studies used transformed cell lines, and studies using normal CD4 lymphocytes did not find this phenomenon [7] [8] [9] [10] [11] . Also, the apoptosis induced in cell lines was not Fas/Fas ligand (FasL)-mediated, but other pathways were [7] [8] [9] . Recently, collagen deposition-associated fibrosis and damaged lymphatic tissues that accompany immune activation have been shown to be correlated inversely with blood CD4 ؉ T cell count [4, 12] . Some studies suggest that there is a significant dysregulation of cytokine responses, which likely, influences T cell susceptibility to apoptosis [13] . Many of these factors may play some roles in CD4 ؉ T cell depletion. However, excessive apoptosis of uninfected CD4 ؉ T cells is thought to be the major reason for depletion of CD4 ؉ T cells [13, 14] .
Our previous studies showed that HIV-1 binding to resting CD4
؉ T cells up-regulated the expression of CD62L, the receptor for homing to lymph nodes, on some cells and enhanced the homing of these cells from the blood into lymph nodes [15] [16] [17] . Subsequent signaling through various homing receptors during the homing process on these abortively infected CD4
؉ T cells induced many of them to undergo apoptosis [16] . These signaling events occur when the cells transendothelial migrate into lymph nodes, and it was shown that CD4 ؉ T cells in the blood of HIV-infected people do home to lymph nodes and bone marrow at increased rates [18] . However, how the secondary signaling through homing receptors on these cells induces apoptosis is not clear. Some studies of CD4 ؉ T cells in HIV-1 ϩ patients stated that HIV-1-induced CD4 ؉ T cell depletion is mediated by Fas-FasL interactions [19, 20] . It has been demonstrated that high levels of Fas susceptibility were found in PBLs before highly active antiretroviral therapy (HAART), and these were reduced significantly after HAART [21] . In addition, after HAART, it was found that the decline in tonsillar viral load was associated with a decrease in the proportion of apoptotic CD4 ϩ T cells within the memory CD28
ϩ Fas ϩ FasL ϩ population, suggesting that HIV-1 induces FasL-mediated CD4 ؉ T cell apoptosis [22] . However, others demonstrated a deficiency in FasL expression and activity in blood cells of HIV-1-infected patients, when compared with uninfected, healthy volunteers [23] . We hypothesize this might be explained if FasL is induced after the cells migrate into lymphoid tissues. Mitra et al. [24] observed that the in vitro spontaneous death of T cells taken from advanced HIV-1-infected patients was not inhibited by suppressing the Fas-FasL pathway, but it is not clear whether this in vitro phenomenon reflects how HIV depletes these cells in vivo. Thus, it is of great interest to determine whether the Fas-FasL pathway is involved in the homing receptor-induced apoptosis of HIV-1-signaled, resting CD4 ؉ T cells. It is known that HIV-1 up-regulates surface expression of Fas upon binding to CD4 ؉ T cells [25] . We hypothesize that signals, through homing receptors on the HIV-1-exposed, resting CD4
؉ T cells, would up-regulate FasL and prime the cells to undergo apoptosis. Blocking of the Fas-FasL interaction should prevent this apoptosis. To test our hypothesis, cell surface FasL expression and apoptosis were determined on HIV-1-exposed CD4 ؉ T cells secondarily signaled through CD62L. Furthermore, anti-FasL antibody and soluble Fas (sFas) were used in blocking experiments of apoptosis.
MATERIALS AND METHODS

Antibodies and other reagents
Unless specified, all mAb specific for human cell surface molecules were obtained from BD Biosciences (San Diego, CA). For CD4 cell purification, a cocktail of purified mAb specific for CD8, CD14, CD19, CD56, HLA-DR, -DP, and -DQ, and glycophorin A was used. Anti-CD25-coated beads and goat antimouse IgG (GAM)-coated beads were purchased from Dynal (Lake Success, NY). For FACS analyses, FITC-or PE-conjugated mAb specific for CD4, CD25, CD95/Fas, CD178/FasL (Ancell, Bayport, MN), and Bcl-2 and AnnexinV-PE were used. For cross-linking of CD4 (RPA-T4) or CD62L (XLCD62L; Clone Dreg56), anti-CD4 and anti-CD62L were used, respectively. For blocking experiments, anti-FasL mAb (Clone NOK1) was used [26] . FITCor PE-labeled mouse or hamster IgG1, IgG2a, and IgG2b isotype controls were applied as needed. The sFas/Fc chimeric protein containing human extracellular domain was purchased from R&D Systems (Minneapolis, MN).
Purification of resting CD4
ϩ T cells
Blood was obtained from HIV-1-negative, healthy human volunteers. PBMC were isolated from heparinized venous blood by centrifugation through lymphocyte separation medium (Mediatech Inc., Herndon, VA) and washed twice with PBS. The cell pellet was resuspended in RPMI-1640 medium (Gibco, Carlsbad, CA), supplemented with 2% human AB serum. CD4 ϩ T cells were purified from PBMC by negative selection using a cocktail of antibodies and magnetic beads (Dynal). Briefly, PBMC were incubated with appropriate amounts of antibody cocktail (anti-CD8, anti-CD14, anti-CD16, anti-CD19, anti-CD56, anti-HLA-DR, -DP, and -DQ, and antiglycophorin A) for 30 min on ice. After incubation with GAM-coated beads at room temperature for 30 min with gentle shaking, the supernatant was recovered after magnetic beadpositive cells were removed using a magnetic separator. Cells were then depleted of CD25 ϩ cells using anti-CD25-coated beads. ϩ T cells were exposed with HIV-1 at a multiplicity of infection (MOI) equal to 1 and cultured in RPMI-1640 medium supplemented with 10% human AB serum, 5 U/ml recombinant IL-2, 100 U/ml penicillin-100 g/ml streptomycin, and 2 mM L-glutamine. In some experiments, HIV-1 was UVinactivated before infection as described [27] . Virus, live or UV-inactivated, did not productively infect resting CD4 cells, as determined by PCR for HIV-1 gag region and p24 antigen-capture ELISA.
XLCD62L
Resting CD ϩ T cells were exposed with or without HIV-1 (live or inactivated) overnight. After three washes, the cells were incubated with mouse antihuman CD4 or CD62L mAb (2 g/10 5 cells) for 30 min on ice. (Each of these antibodies has been shown to be able to signal via cross-linking the receptor to which they bind [26] .) Cells were washed three times and cultured in 96-well plates in supplemented media containing GAM IgG antibody (0.5-1 g/10 5 cells). In some experiment, plate-coated GAM was used in place of a soluble one. For the coating of GAM to the plates, 50 l GAM in coating buffer (100 g/ml in 30 mmol/L NaHCO 3 , 15 mmol/L Na 2 CO 3 , pH 9.6) was added to each well of 96-well plates, incubated at 4°C overnight, and washed five times with PBS.
Flow cytometric analysis
For surface staining, cells were incubated with normal mouse IgG for 15 min to block nonspecific binding sites, as well as to bind to any free arms of GAM IgG cross-linking antibody. Then, cells were stained with various FITC-or PE-conjugated mAb on ice for 30 min. Intracellular staining for Bcl-2 was measured, according to protocols provided by BD Biosciences. Briefly, cells were permeabilized with cytofix/cytoperm buffer for 20 min on ice, and intracellular staining was performed for 30 min on ice with PE-conjugated anti-Bcl-2 mAb. Cell staining was detected on a FACScan and analyzed using CellQuest software (Becton Dickinson, San Jose, CA).
RT-PCR for FasL mRNA
For the determination of FasL mRNA, RT-PCR was performed as described [28] . In brief, total RNA was extracted with RNeasy mini kit (Qiagen, Inc., Valencia, CA) according to the manufacturer's protocol. RT of RNA to cDNA and PCR were performed, according to the protocol of the OneStep RT-PCR kit (Qiagen). FasL-specific primer pairs and GAPDH were purchased from Sigma Chemical Co. (St. Louis, MO). Premier sequences for FasL 5Ј sense and 3Ј antisense were CTGGTGGCTCTGGTTGGAAT and GTTTAGGGGCTGGTT-GTTGC, respectively. GAPDH was used as an internal control. All the RNA samples pre-ran the PCR without RT and found no detected FasL signals.
Apoptosis determinations
Cells undergoing apoptosis were detected by Annexin V-PE staining, and necrotic cells were determined by 7-amino-actinomycin (7-AAD) staining, according to protocols provided by BD Biosciences. Apoptotic cells were gated on Annexin V ϩ 7-AAD -cells.
Statistical analysis
Differences between experimental groups were examined using the Student's t-test. A difference in mean values was considered significant when the P value was Ͻ0.05 or very significant when the P value was Ͻ0.01.
RESULTS
HIV-1 exposure resulted in up-regulated expression of CD62L on resting CD4 ϩ T cells
We showed previously that resting CD4 ϩ T cells abortively infected with HIV-1 up-regulated CD62L, which is required for homing into lymph nodes [15, 16] . In contrast, Marschner et al. [29, 30] reported CD4 ligation by anti-CD4 mAb crosslinking or by coculturing with HIV-producing Jurkat cells, induced shedding of CD62L, which reduces the homing of T cell to peripheral lymph nodes. To clarify the effect of HIV-1 on CD62L expression, we exposed purified, resting CD4 ϩ T cells (purity Ͼ95%) with virus (HIV-1 213 or HIV-1 BaL ), freshly collected or stored at -70°C. Confirming our previous observations, HIV-1 213 and HIV-1 BaL did up-regulate CD62L on CD4 ϩ T cells (Fig. 1, A and B) . The effects on CD62L expression could be observed by 24-h postexposure and reached a peak at 48 h and then started declining by 72 h (Fig.  1B) . Cross-linking of CD4 by anti-CD4 plus soluble GAM up-regulated the CD62L on CD4 ϩ T cells (Fig. 1C) . However, if CD4 were cross-linked by anti-CD4 plus plate-coated GAM instead, a decrease of CD62L was observed (Fig. 1C ), similar to observations by Marschner et al. [29, 30] . It is interesting that consistent with our previous report [29, 30] , HIV-1 exposure could not significantly alter expression of other home receptor molecules such as CD44 and CD11a (data not shown).
XLCD62L on HIV-1-exposed, resting CD4
ϩ T cells induced apoptosis and up-regulated FasL expression Consistent with our previous results, increased expression of Fas was also observed 24 -72 h after HIV-1 213 or HIV-1 BaL exposure (Fig. 1, D and E) . As detected by Annexin V staining in Figure 2 , A and B, 2-3 days after XLCD62L, significant apoptosis was observed on HIV-1 213 -or HIV-1 BaL -exposed CD4 ϩ T cells but not mock-treated cells. Similarly, crosslinking of other homing receptors CD44 or CD11a with mAb induced 25-35% of HIV-1-exposed, resting CD4 ϩ T cells to undergo apoptosis. Of note, HIV-1 or XLCD62L alone did not result in apoptosis (Fig. 2A) .
To determine how signaling through CD62L induces HIVsignaled CD4
ϩ T cells to undergo apoptosis, we showed previously that HIV-1 exposure up-regulated Fas expression on CD4 ϩ T cells, suggesting the possible roles of Fas in apoptosis [16] . In this study, we further examined the possible involvement of FasL in apoptosis by determining FasL expression on HIV Fig. 3, A and B) . Similarly, cross-linking other homing receptors, CD44 and CD11a, induced FasL expression on HIV-1-exposed CD4 ϩ T cells (data not shown). Furthermore, as detected by RT-PCR, FasL mRNA was also induced by XLCD62L in HIV-1 213 -exposed CD4 ϩ T cells (Fig. 3C) . It is interesting that XLCD62L alone upregulated FasL transcription but not its expression at protein levels, suggesting the level of mRNA expression does not necessarily predict the level of protein expression (Fig. 3, B and C).
Apoptosis of HIV-1-exposed, resting CD4 ϩ T cells upon stimulation with XLCD62L was blocked by sFas or anti-FasL mAb
We next examined whether XLCD62L-induced apoptosis on HIV-1-exposed, resting CD4 ϩ T cells is mediated by Fas/FasL, by blocking of apoptosis with sFas or anti-FasL mAb. For this purpose, sFas or anti-FasL mAb was added into CD4 ϩ T cell cultures, and then apoptosis was determined by Annexin V staining. As shown in Figure 4 , XLCD62L-induced apoptosis of HIV-1 213 -exposed CD4 ϩ T cells was inhibited significantly by sFas or specific blocking anti-FasL mAb.
XLCD62L of HIV-1-exposed, resting CD4 ϩ T cells down-regulated Bcl-2 expression
As Bcl-2 is a potent inhibitor of apoptosis [31, 32] , and Bcl-2 expression has been reported to be impaired in T cells from HIV-1-exposed individuals [33] [34] [35] , we sought to investigate the Bcl-2 expression in HIV-1-exposed CD4 ϩ T cells subsequent to XLCD62L. Bcl-2 expression was found to be downregulated significantly on HIV-1-exposed CD4 ϩ T cells subsequent to XLCD62L (HIV-1 213 , MFIϭ226Ϯ25, PϽ0.05; HIV-1 BaL , MFIϭ246Ϯ21, PϽ0.01) compared with XLCD62-signaled, mock controls (MFIϭ400Ϯ25; Fig. 5, A and B) . However, HIV-1 or XLCD62L alone did not alter the Bcl-2 expression (Fig. 5B) .
DISCUSSION
In this study, we demonstrated that HIV-1 binding up-regulated Fas expression on resting CD4 ϩ T cells, and additional ϩ T cells [16] , demonstrating specificity of Fas-FasL-mediated apoptosis following signaling through homing receptor(s). However, HIV-1 only up-regulates the expression of CD62L expression but not the expression of other homing receptors such as CD44 and CD11a, suggesting that the signals for enhanced homing are mainly via up-regulated CD62L. The subsequent signals for apoptosis could be through multiple homing receptors or any one of them.
These studies are of particular importance in light of conflicting data regarding the effects of HIV-1 on homing and homing receptor regulation (Fig. 1, A-C) . Early studies showed that CD4 ϩ lymphocytes increase in number in lymph nodes (lymphadenopathy) when blood levels of these cells begin to drop significantly [36, 37] , suggesting the possibility of enhanced homing of CD4 ϩ lymphocytes from the blood into lymph nodes. Furthermore, in agreement with these observations, our previous studies showed that HIV-1-abortive infection of resting CD4 ϩ T cells up-regulated the expression of CD62L, the receptor for homing to lymph nodes, and these cells enhanced homing from the blood into lymph nodes [15] [16] [17] . However, in contrast with these observation, studies by Marschner et al. [29, 30] showed that extensive CD4 crosslinking by plate-coated, anti-CD4 or contact with HIV-producing Jurkat cells led to CD62L shedding, which would reduce homing of T cells to peripheral lymph nodes. An explanation for shedding of CD62L in those studies may lie in the difference in experimental techniques. We used virus, which was freshly harvested as supernatants from infected CEM cells, to bind to resting CD4 ϩ T cells. In contrast, Marschner et al. [29, 30] T cells was performed as described in Figure 2 . sFas (10 g/ml), anti-FasL mAb (NOK1, 20 g/ml), or control IgG was added, and 3 days later, cells were harvested for Annexin V staining. Representative histograms are shown.
of fusion or negative factors released from Jurkat cells is not known. Comparing several cell lines that are used for HIV-1 culture on their cytokine production, we found that CEM cells produced undetectable IL-10. However, other cell lines such as H-9 cells produced high levels of IL-10 (500 -700 g/ml), which can inhibit CD62L expression (data not shown). TCR activation of T cells derived from transformed cell lines or hybridomas results in induction of FasL expression and rapid susceptibility to Fas-mediated apoptosis. In primary T lymphocytes, however, the process of activation-induced cell death requires a more prolonged period of time [38 -40] . Tateyama et al. [28] demonstrated that XLCD4 on CD4 ϩ T cells not only led to Fas up-regulation but also primed the CD4 ϩ T cells to express FasL upon anti-CD3 stimulation and rendered the T cells susceptible to Fas-mediated apoptosis. We showed previously that HIV-1 binding to resting CD4 ϩ T cells induced these cells to home into lymph nodes faster and induced apoptosis upon stimulation by cross-linking of homing receptors [15] [16] [17] . Our present study shows that HIV-1 exposure, followed by cross-linking the homing receptor CD62L on CD4 ϩ T cells, induced FasL expression and sensitized the cells for Fas-mediated apoptosis (Figs. 2 and 3) . One of the major observations in this study is that apoptosis of HIV-1-exposed, resting CD4 ϩ T cells, in which CD62L was crosslinked, could be inhibited significantly by blocking anti-FasL antibodies or sFas (Fig. 4) . This indicated that apoptosis of HIV-1-exposed, resting CD4 ؉ T cells, subsequently signaled through the homing receptor, is Fas-FasL-mediated. It is interesting that apoptosis was detected in resting CD4
؉ T cells exposed with X4 virus strain (HIV-1 213 ) or R5 virus (HIV-1 BaL ) strain, subsequently signaled by XLCD62L, indicating that this is a common property of HIV-1 (Fig. 2) . Furthermore, such effect seems to be independent of HIV-1 replication, as UVinactivated, HIV-1-exposed, resting CD4 ؉ T cells, upon XLCD62L, underwent apoptosis as well (data not shown). Although recent observations showed that HIV or SIV could productively infect resting, naïve CD4
؉ T cells in vivo [41, 42] or naïve CD4
؉ T cells cultured in conditioned media [43] or with macrophages in vitro [44] , we have not detected any productive infection in resting CD4
؉ T cells derived from PBMC by p24 antigen-capture ELISA and PCR for virus gag sequence (data not shown), indicating our culture system lacked the factors [41, 42] that exist in vivo or conditioned media. Even if some nondivided CD4 ϩ T cells in vivo were infected productively, that does not necessarily mean that they will be killed by virus. R5 virus is not cytopathic, but CD4 ϩ T cells are eliminated in the gut early, when only that virus is present. In fact, it is likely that this early gut CD4 ϩ T cell depletion involves homing, as the cells depleted in lamina propria, where CD4 ϩ T cells migrate in from the blood and the Peyer's patches, which contain most of the productively infected CD4 cells that are not depleted. Consistent with our current in vitro findings, Li et al. [45] found Fas-FasL-mediated apoptotic pathway in lamina propria CD4 ϩ T cells, indicating even in acute infection, apoptosis contributes to CD4 ϩ T cell depletion. Futhermore, Boirivant et al. [46] observed that lamina propria CD4 ϩ T cells selectively up-regulated Fas and FasL and underwent apoptosis when exposed to recombinant gp120 upon the CD2 pathway stimulation in vitro. Based on our data, we proposed that in vivo, CD4
ϩ T cells are infected with HIV in Peyer's patches, where they may get the signals for homing fast and up-regulated Fas and get the further signals, such as FasL, through interaction between homing receptors and their ligand on lamina propria and finally, undergo apoptosis in lamina propria. We are currently working on the effects of HIV on gut homing receptor ␣4␤7 and consequence of cross-linking of ␣4␤7 on the HIV-exposed CD4 ϩ T cells derived from lymph node bioautopsy. Although the evidence was circumstantial, susceptibility of CD4 ϩ T cells to apoptosis induced by XLCD62L appears to be mediated by down-regulation of Bcl-2 (Fig. 5) . These results provide a molecular basis to explain the mechanism of homing receptor signaling-induced, resting CD4 ؉ T cell apoptosis. Previous studies have been shown that CD4 activation primes T cells for apoptosis if a second signal from TCR engagement or if accessory cells were provided [47] [48] [49] . It is known that a repeated signal through TCR induces the expression of FasL [39, 40, 50] , and APC constitutively express FasL [51, 52] . In this study, we found signals, which through homing receptor, such as XLCD62L, could provide a similar second signal to induce FasL (Fig. 3) . Together with the Fas upregulation within the same CD4
؉ T cell population (Fig. 1, D  and E) , the induction of FasL resulted in significant CD4 ؉ T cell apoptosis in vitro. Unlike previous reports [53] , in which XLCD4 induced FasL expression rapidly in a transient manner, we could not find that HIV-1 signals alone could induce any FasL (Fig. 3, B and C) . This suggests the CD4 signaling, via an interaction with HIV-1 virions or via envelope proteins expressed on the surface of infected cells, is not the same as XLCD4 through anti-CD4 antibodies. Furthermore, it is possible that HIV-1 could induce FasL expression slightly, but it sheds quickly in a manner as described previously [26] . However, against this possibility, the addition of a matrix metalloproteinase inhibitor did not alter FasL expression significantly on HIV-1-exposed CD4 ϩ T cells, with or without second signals through XLCD62L (data not shown). Tateyama et al. [28] and others [38, 54] documented the difficulty in demonstrating surface FasL expression on lymphocytes. In the present study, we could detect FasL expression on the CD4 ϩ T cells by flow cytometry, as described by Algeciras et al. [53] . The major differences between previous observations and those in this report are the methods to purify CD4 
CD25
-cells [55] . It remains to be determined whether CD4 ϩ CD25 ϩ cells inhibit FasL induction in CD4 ϩ CD25 -cells. With respect to the in vivo relevance of our findings in the context of HIV-1 pathogenesis, our data implicate the following scenario to be operative in vivo and may act as a mechanism for the death of uninfected CD4 ϩ cells. Resting CD4 ϩ lymphocytes in lymphoid tissues (in gut, lymph nodes, etc.), coming into contact with HIV-1 virions, productively infected cells, or HIV-1-coated, follicular dendritic cells, result in induction of a partially activated phenotype, including up-regulation of homing receptors and Fas. Because of normal lymph node/ blood circulation, in which most lymphocytes in lymphoid tissues migrate back to the blood within 2 days [56] , many of these cells will end up back in the blood at the time of maximum-induced expression of homing receptors. These cells would then home rapidly to peripheral lymph nodes or gutassociated, lymphatic tissue, dependent on the type of homing receptors (e.g., CD62L for peripheral lymph nodes; ␣4␤7 for gut). Following transendothelial migration, these CD4 ϩ T cells receive signals through homing receptors, resulting in induction of FasL expression on some of the cells and rapid susceptibility of them to Fas-mediated apoptosis. Consequently, together with the increased Fas expression within the same CD4 ϩ T cell population, approximately one-third of them would be depleted, and they do not produce HIV-1 [18] . In support of this review, features that are characteristically associated with HIV-1 infection include the following. As CD4 lymphocytes disappear in the blood, their numbers do not drop, and the CD4/CD8 ratios do not invert in lymph nodes until late in disease [57] ; there is increased apoptosis of uninfected cells, mainly localized in lymph nodes or gut-associated lymphatic tissue [6, 45, 58] but not in the blood [59, 60] ; there is increased FasL-expressing cells with the morphology of macrophages and lymphocytes, and the degree of FasL in vivo has been shown to be correlated with the degree of apoptosis [61] . Steroids, which are known to down-regulate CD62L and retard lymph node homing, have been shown to stop reduction of CD4 cells in the blood of patients [62] . This may be the consequence as control of aberrant homing signals for the marked reduction in apoptosis. Future studies, testing whether inhibition of lymph node homing or homing receptor induction of apoptosis would prevent depletion of CD4 ϩ cells in patients, are needed.
